14.000
+0,00%
2026-10-19
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -84.3% | -49.0% | 0 / 3 | +20.3% | -0.53 pp | -0.41 pp | +1.8% | 2.56 | 69.04 | 3.491 | +20,3% | 12,2 | −44,8% | 69.04 | 37.81 | +82,6% |
| Pts | 0 | 0 | 0 | 12 | 4 | 4 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 14.000 (close price on 2026-10-19)EPS (TTM): 202,8
Financial charts
1.Revenue & growth
VND bn3.491Q2/26
1.Revenue & growth
VND bn3.491Q2/26
2.Profit & growth
VND bn1,89Q2/26
3.Profit mix (Penman)
VND bn114Q2/26
4.Margins & cost structure
%8.4%Q2/26
5.Returns & cash cycle
% · days4.2%Q2/26
6.Earnings quality & cash
VND bn171Q2/26
7.Asset structure
VND bn10.221Q2/26
8.Funding & debt health
VND bn · times10.221Q2/26
9.Revenue backlog
VND bn221Q2/26
10.Valuation
times · %69,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %11Q2/26
Adjusted EPS growth, latest quarter
-85.0%
Average adjusted EPS growth, 3 quarters
-49.3%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
5.0%
Source: vnstockData through Q2/26